Specifically, UCHL1 acts as a tumor suppressor by stabilizing p53 in breast cancer and hepatocellular carcinoma, whereas it acts as a tumor promoter by enhancing the PI3K/Akt signaling pathway in non-small cell lung cancer and melanoma [17,18,19,20]. Here, AKT1 is linked to neoplasm.